Soluble forms of CD40 inhibit biologic responses of human B cells

William C. Fanslow(Laboratoire d'Innovation Thérapeutique), Richard J. Armitage(Unknown), Edward A. Clark(St Vincent Hospital), Kenneth H. Grabstein(Corixa Corporation), Dirk Anderson(IDEX Corporation (United States)), David Cosman(IDEX Corporation (United States))
The Journal of Immunology
July 1, 1992
Cited by 155


Related Papers